Subject: Insulin donation & need in GEO
From: "DOMENTE, Silviu" <[email-masked]>
To: Tamar Gabunia <[email-masked]>
Date: Mon, 27 Apr 2020 07:46:03 +0000

Dear Tamar,

There is a possibility to get a six-month donation of freshly produced insulin from Novo Nordisk, for countries whose health systems/supplies are disrupted by COVID. They also offer to deliver directly to health facilities.

The donation is managed by the NCD programme in WHO Headquarters (HQ), under the existing long-term agreement with Novo Nordisk. HQ have prepared a concept note to describe the offer - attached.

I was asked to check the following with the Georgian health authorities:

How relevant this donation would be for
the country’s context

Where at country level the insulin is expected to be delivered/distributed (central hospital, other HC facilities/implementing partners)

Please indicate the number of kits requested

Human Insulin (100 UI/ml vial) Protaphane ® (long-acting insulin)

Human Insulin (100 UI/ml vial) Actrapid ® (fast-acting insulin)

Human Insulin (100 UI/ml vial) Mixtard 30 ® (mix-acting insulin)

Glucagen Hypokit ® (glucagon for injection 1mg/ml) -

Confirm Products are part of the national EML and national protocols

Comments on how needs have been estimated

Products is part of the last national quantification (2021-2022) - Y/N

Have you secured enough  storage capacity (central/facility level) (Insulin should be stored in a refrigerator at a temperature between 2°C – 8°C)

Comments on storage capacity

Looking forward for the feedback on the above and will keep you updated on any progress.

Thank you and best regards,

Silviu